Free Trial

Massachusetts Financial Services Co. MA Acquires 68,515 Shares of Bath & Body Works, Inc. (NYSE:BBWI)

Bath & Body Works logo with Retail/Wholesale background

Massachusetts Financial Services Co. MA boosted its position in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 48.0% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 211,120 shares of the company's stock after buying an additional 68,515 shares during the quarter. Massachusetts Financial Services Co. MA owned approximately 0.10% of Bath & Body Works worth $6,401,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Vanguard Group Inc. raised its holdings in Bath & Body Works by 0.7% during the 4th quarter. Vanguard Group Inc. now owns 28,199,787 shares of the company's stock valued at $1,093,306,000 after buying an additional 208,036 shares during the last quarter. T. Rowe Price Investment Management Inc. increased its position in Bath & Body Works by 4.3% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 10,235,086 shares of the company's stock valued at $396,815,000 after purchasing an additional 422,973 shares during the period. Price T Rowe Associates Inc. MD increased its position in Bath & Body Works by 5.5% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 8,494,089 shares of the company's stock valued at $329,317,000 after purchasing an additional 445,887 shares during the period. Alliancebernstein L.P. grew its position in shares of Bath & Body Works by 35.6% in the 4th quarter. Alliancebernstein L.P. now owns 5,178,447 shares of the company's stock worth $200,768,000 after buying an additional 1,360,264 shares during the period. Finally, Anomaly Capital Management LP grew its position in shares of Bath & Body Works by 38.3% in the 4th quarter. Anomaly Capital Management LP now owns 4,860,876 shares of the company's stock worth $188,456,000 after buying an additional 1,346,752 shares during the period. 95.14% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on BBWI. JPMorgan Chase & Co. upped their price target on shares of Bath & Body Works from $41.00 to $43.00 and gave the stock an "overweight" rating in a research note on Monday, May 19th. Telsey Advisory Group restated an "outperform" rating and set a $38.00 price target (down previously from $43.00) on shares of Bath & Body Works in a report on Thursday, May 29th. Piper Sandler set a $39.00 target price on Bath & Body Works and gave the stock an "overweight" rating in a report on Thursday, May 15th. UBS Group boosted their price objective on Bath & Body Works from $32.00 to $36.00 and gave the company a "neutral" rating in a report on Tuesday, May 20th. Finally, Morgan Stanley dropped their price objective on Bath & Body Works from $49.00 to $43.00 and set an "overweight" rating for the company in a report on Tuesday, May 6th. Four equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $42.00.

View Our Latest Research Report on BBWI

Bath & Body Works Stock Performance

NYSE:BBWI opened at $31.79 on Friday. Bath & Body Works, Inc. has a one year low of $24.94 and a one year high of $41.87. The stock has a market cap of $6.73 billion, a PE ratio of 8.48, a P/E/G ratio of 1.07 and a beta of 1.72. The stock has a 50 day moving average price of $30.16 and a 200 day moving average price of $32.25.

Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its quarterly earnings data on Thursday, May 29th. The company reported $0.49 earnings per share for the quarter, topping the consensus estimate of $0.47 by $0.02. The company had revenue of $1.40 billion during the quarter, compared to analyst estimates of $1.42 billion. Bath & Body Works had a negative return on equity of 47.44% and a net margin of 11.10%. The firm's revenue for the quarter was up 2.9% compared to the same quarter last year. During the same period in the prior year, the business posted $0.38 earnings per share. As a group, analysts predict that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, June 20th. Stockholders of record on Friday, June 6th were given a dividend of $0.20 per share. The ex-dividend date was Friday, June 6th. This represents a $0.80 annualized dividend and a dividend yield of 2.52%. Bath & Body Works's dividend payout ratio is currently 21.33%.

About Bath & Body Works

(Free Report)

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

Featured Articles

Institutional Ownership by Quarter for Bath & Body Works (NYSE:BBWI)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Bath & Body Works Right Now?

Before you consider Bath & Body Works, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.

While Bath & Body Works currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters
This Strategy Beat the S&P—And Most Investors Ignore It
NVDA Greenlight: China Sales Spark 50% Rally Potential

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines